Theriva Biologics receives CHMP scientific advice on VCN-01 Phase 3 design

Theriva Biologics (TOVX) announced the receipt of Scientific Advice from the Committee for Medicinal Products for Human Use ...
Healio

Intra-arterial gemcitabine extends PFS in locally advanced pancreatic cancer

Please provide your email address to receive an email when new articles are posted on . Intra-arterial administration of gemcitabine conferred a median PFS benefit of 8 months when compared with ...
Healio

Perichemotherapy antibiotics improve PDAC survival in patients treated with gemcitabine

Please provide your email address to receive an email when new articles are posted on . Antibiotic receipt in the month before or after gemcitabine treatment improved survival in metastatic pancreatic ...
TipRanks on MSN

Relmada’s BOOST phase 3 bladder cancer trial sets up a new catalyst for RLMD investors

Relmada Therapeutics Inc ($RLMD) announced an update on their ongoing clinical study. Relmada Therapeutics is preparing to launch a late-stage ...
Renal & Urology News

Benefit of Adding Immunotherapy to Chemo May Vary According to Platinum Agent Used

Immunotherapy improved overall survival when added to cisplatin-gemcitabine but not when added to carboplatin-gemcitabine. Adding immunotherapy to platinum-gemcitabine chemotherapy can improve ...

Health Canada Approves TEVIMBRA® (tislelizumab for injection) in Combination with Gemcitabine and Cisplatin for the First-Line Treatment of Adult Patients with Recurr…

BeOne Medicines, a global oncology company, today announced that Health Canada has granted a Notice of Compliance (NOC), ...
Seeking Alpha

Helix Biopharma Corp. Enters into Asset Purchase Agreement to Acquire Oral Gemcitabine Chemotherapy Compound

December 2, 2024 –TheNewswire –(Toronto, Ontario) – Helix BioPharma Corp. (HBP:CA) (TSX: “HBP”, OTC PINK: “HBPCD”, FRANKFURT: “HBP0”) (“Helix”or ...